Clinical Trials Browser

Has results × Colonic Neoplasms × Erlotinib Hydrochloride × Clear all

NCT00940316 2019-05-07

Dual Epidermal Growth Factor Receptor Inhibition With Erlotinib and Panitumumab With or Without Chemotherapy for Advanced Colorectal Cancer

Phase 2 Completed

28 enrolled 11 charts

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00754494 2015-01-06

Erlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or Adenoma

Phase 2 Completed

45 enrolled 18 charts

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Adenomatous Polyps